Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025)

Oramed Pharmaceuticals (ORMP) posted Divestments of $2.8 million for Q3 2025, up 297.88% on a QoQ basis from $706000.0 in Q2 2025.

Oramed Pharmaceuticals (ORMP) Divestments (2011 - 2025) Analysis & Trends

Oramed Pharmaceuticals' Divestments history runs 3 years deep, the most recent figure standing at $2.8 million for Q3 2025.

Quarterly Divestments changed N/A year-over-year to $2.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $6.3 million (changed N/A YoY) and the FY2025 annual result came in at $6.3 million, changed N/A from the prior year.
Divestments was $2.8 million for Q3 2025 at Oramed Pharmaceuticals, up from $706000.0 in the prior quarter.
Across five years, Divestments topped out at $2.8 million in Q3 2025 and bottomed at $706000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-32.58 Mn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Oramed Pharmaceuticals	170.25 Mn	170.25 Mn	-	-

Download Data